Medicare and Medicaid open coverage of anti-obesity drugs for heart patients
The Centers for Medicare and Medicaid Services said that anti-obesity drugs should be covered for patients getting them for additional medical conditions, a move that could meaningfully expand access for patients in the US government health programs.
A CMS spokesperson told Endpoints News that the centers have issued guidance to Medicare Part D plans stating that anti-obesity medications with FDA approval for an additional medically accepted indication, such as reducing the risk of major cardiovascular events, can be covered for that use.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
